KRW 6560.0
(-4.51%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 107.36 Billion KRW | 9.12% |
2022 | 98.39 Billion KRW | 60.5% |
2021 | 61.3 Billion KRW | 25.42% |
2020 | 48.87 Billion KRW | 3.72% |
2019 | 47.12 Billion KRW | -35.74% |
2018 | 73.33 Billion KRW | -2.93% |
2017 | 75.55 Billion KRW | -3.45% |
2016 | 78.24 Billion KRW | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 108.54 Billion KRW | 1.09% |
2024 Q2 | 110.68 Billion KRW | 1.97% |
2023 Q4 | 107.36 Billion KRW | -1.02% |
2023 FY | 107.36 Billion KRW | 9.12% |
2023 Q3 | 108.47 Billion KRW | 0.26% |
2023 Q2 | 108.19 Billion KRW | 5.01% |
2023 Q1 | 103.03 Billion KRW | 4.71% |
2022 Q2 | 100.94 Billion KRW | 67.2% |
2022 Q1 | 60.37 Billion KRW | -1.52% |
2022 Q3 | 102.31 Billion KRW | 1.36% |
2022 Q4 | 98.39 Billion KRW | -3.82% |
2021 Q4 | 61.3 Billion KRW | 0.02% |
2021 Q3 | 61.29 Billion KRW | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 320.54 Billion KRW | 66.504% |
InBody Co.,Ltd | 274.45 Billion KRW | 60.879% |
Seegene, Inc. | 1251.45 Billion KRW | 91.42% |
i-SENS, Inc. | 498.81 Billion KRW | 78.475% |
Ray Co., Ltd. | 259.55 Billion KRW | 58.633% |
Gencurix Inc. | 33.5 Billion KRW | -220.488% |
Sugentech Inc. | 133.18 Billion KRW | 19.384% |
L&C Bio Co., Ltd | 262.23 Billion KRW | 59.055% |